Navigation Links
Snail venom Found To Ease Pain In Cancer Victims

Laboratory research has found evidence that the venom that the snails inject to immobilize their prey might have beneficial effects // on some heart problems, strokes, central nervous system disorders and other ills.
The latest study involved the experimental drug ziconotide, a laboratory-made equivalent of a compound in the venom of the small Conus Magus cone snail, which lives in shallow tropical saltwater.

The snail-venom research involved 111 patients ages 24 to 85 in the United States, Australia and the Netherlands. All were treated with a small, battery-operated pump implanted in their abdomens and attached to a catheter that delivered continuous medication or a dummy drug into fluid surrounding the spinal cord. Treatment lasted about 10 days; most patients were not hospitalized during that time.

The infusions produced significant relief in patients whose pain did not respond to more conventional drugs such as morphine.Pain relief was moderate to complete in 53 percent of ziconotide patients, compared with about 18 percent of the placebo group.

Serious side effects occurred in 22 ziconotide patients and four placebo patients. Subsequent research has shown that starting patients on lower doses reduces the risks, and many have remained on treatment for more than a year.

Specialists feel this new, promising kind of treatment could relieve thousands of cancer patients who suffer from intractable pain and who don't respond to the normal, conventional treatments.

Federal approval for the drug is still being sought and researchers say they expect it to become commercially available within the year.
'"/>




Page: 1

Related medicine news :

1. Painkiller Based on Sea Snail Venom Made Available in Britain
2. Venomous Cone Snails Relieve Chronic Back Pain
3. Health Benefits from the Ocean Snail
4. A New Target for Painkillers: Snail Toxins Show the Way
5. Sea Snails May Aid Chronic Pain Treatments – Says Researcher
6. Snake venom a treatment for digestive disease
7. Fluoride Found Effective in Osteoporosis
8. Implantable Contact Lens Found Safe and Effective
9. Cancer hazard Found With Animal-Based Nutrients
10. Processed Meat, Diabetes connection Found
11. Night Time Aspirin Regimen Found to Reduce Blood Pressure
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/22/2017)... ... April 22, 2017 , ... Ecommerce sales have grown every year ... be $394.9 billion. The consequences of rapid innovation and growth are often neglected ... technology, it is every business and individual’s job to give something back to the ...
(Date:4/22/2017)... ... April 22, 2017 , ... PharmacyChecker.com released ... save an average of 70% when buying medication online from Canadian pharmacies verified ... when purchasing from other countries. The report (chart below) compares U.S. and foreign ...
(Date:4/22/2017)... Juan Capistrano (PRWEB) , ... April 22, 2017 , ... The San Juan Capistrano ... recently released a parenting report outlining the need for summer camps to provide physical activities ... The Importance of Physical Activity In Summer Camps , With an increase in specialty camps ...
(Date:4/21/2017)... ... 2017 , ... Providing broad access to life-saving drugs and rewarding the innovators ... way to address this problem. , That was the message from Dana Goldman, PhD, ... the University of Southern California, who served as the keynote speaker for Western University ...
(Date:4/21/2017)... ... April 21, 2017 , ... Contrary ... that youth violence is declining—and at noteworthy rates. Between 2002 and 2014, Salas-Wright ... people involved in violence in the United States. The study, Trends in ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 Cardiology devices segment is anticipated to reach ... The Cardiology Devices segment is likely to create absolute $ ... 2018 over 2017. By the end of 2027, Cardiology Devices ... US$ 700 Mn, expanding at a CAGR of 18.4% over ... Asia Pacific reprocessed medical devices market in ...
(Date:4/19/2017)... DALLAS , April 19, 2017  Vanderbilt University ... first patients in Nashville , Tennesse ... Lower Esophageal Sphincter Stimulation for GERD (LESS GERD) trial. ... to provide long-term reflux control by restoring normal function ... nearly 65 million people in the United ...
(Date:4/19/2017)... , April 19, 2017  Novartis today ... the National Heart, Lung, and Blood Institute (NHLBI) ... that 58% of patients with treatment-naïve severe aplastic ... when treated with eltrombopag at the initiation of ... The study evaluated three sequential treatment groups, or ...
Breaking Medicine Technology: